How Long Should Estrogen Be Supplemented After Embryo Transfer?

SIGN IN HOW IT WORKS ABOUT US SIGN IN Navigation Menu Home » Infertility » How long should estrogen be supplemented after embryo transfer? How long should estrogen be supplemented after embryo transfer?

Welcome to Medivizor!

You're browsing our sample library. Feel free to continue browsing. You can also sign up for free to receive medical information specific to your situation.

Sign Up Continue

Posted by Medivizor on Nov 7, 2021 in Infertility | 0 comments

Share

In a nutshell

This study evaluated how long estrogen should be used during artificial cycle frozen embryo transfer (FET). It found that stopping estrogen at 6 weeks of pregnancy reduced miscarriages compared to continuing to 12 weeks. Stopping at 6 weeks also led to fewer pregnancy complications.

Some background

FET is a common infertility technique, in which a frozen embryo is transferred to the uterus. FET uses embryos preserved from an earlier cycle of in vitro fertilization (IVF). In order for a FET to be successful, the lining of the uterus must be receptive to an embryo implanting. One way to do this is to time the FET for after ovulation when the uterus is receptive. Alternately, artificial cycle FET uses injections of hormones including estrogen to prepare the uterus. Estrogen is a hormone which is high in the early part of the menstrual cycle, and causes changes throughout the body. One role of estrogen is to thicken the lining of the uterus. The body has several types of estrogen. Estradiol is the type of estrogen used to prepare for a FET.

Around when the embryo is transferred, supplements of progesterone are used in addition to estradiol. This hormone maintains the lining of the uterus. When using an artificial cycle, the ovary does not release its own progesterone. If the woman becomes pregnant, the developing placenta begins to release estrogen and progesterone around the fifth week. For women using artificial cycle FET, estradiol and progesterone are typically taken until 10 to 12 weeks. However, it is not clear how long estradiol should be used in artificial cycle FET.

Methods & findings

This study recruited 291 patients who were undergoing FET using an artificial cycle. All of the patients had their body’s own hormone levels reduced using the GnRH agonist buserelin (Suprefact). Then they received estradiol valerate to prepare the lining of the uterus. After the FET, all patients received progesterone, and continued taking estradiol.

6 weeks after the FET, 64 patients had a pregnancy visible on ultrasound. 32 patients were randomly assigned to the 6-week estrogen (6WE) group. This group continued to take progesterone but stopped taking estradiol after 6 weeks. The other half continued taking both medications until 12 weeks after the FET.

After 12 weeks, the 6WE patients had a significantly lower miscarriage rate (3.13% vs. 18.75%). The average blood levels of estradiol and progesterone were similar in the two groups. There were significantly fewer pregnancy complications for the 6WE group. 92.6% of 6WE patients did not have any complications, versus 54.5% of the comparison group. These complications included cerclage, a procedure to sew the entrance of the uterus shut to prevent preterm birth. They also included preeclampsia and diabetes.

The bottom line

This study found that stopping estradiol after the pregnancy is visible on ultrasound reduced miscarriage for women undergoing artificial cycle FET. It also found that stopping estradiol early reduced pregnancy complications.

The fine print

This study had a small number of patients and should be confirmed with larger trials. Also, artificial cycle FET has a higher rate of miscarriage than other types of FET which include ovulation.

Published By :

Archives of Gynecology and Obstetrics

Date :

Sep 24, 2021

Original Title :

Duration of estradiol supplementation in luteal phase support for frozen embryo transfer in hormone replacement treatment cycles: a randomized, controlled phase III trial.

Share Tags: Library Item, Ongoing treatment(s)-In vitro fertilization (IVF), Research

To receive all the cutting-edge updates personally relevant to you

Subscribe Today

(free and private)

Sign Up Search for: In association with:

Categories

• Benign prostatic hyperplasia
• Blog
• Brain Health
• Breast cancer
• Cancer
• Colorectal cancer
• Coronary artery disease
• Coronavirus / COVID-19
• Diabetes mellitus
• Erectile dysfunction
• Hodgkin's lymphoma
• Hypertension
• Impaired driving
• Infectious Disease
• Infertility
• Kidney stones
• Leukemia
• Lung cancer
• Lymphoma
• Melanoma
• Men's Health
• Mental Health
• Multiple Myeloma
• Nocturia
• Non-Hodgkin lymphoma
• Overactive bladder
• Parkinson's Disease
• Prostate cancer
• Rare disease
• Rheumatoid Arthritis
• Stroke
• Urinary incontinence
• Urinary tract infection

Recent Posts

• Getting “Wild Type” Measles Has NO Benefits
• The Vagus Nerve and Mind-Body Connection
• Colorectal Cancer at 17: Early Screening Saves Lives
• Vaccines Attack a Powerful Foe: Bird, Pig and Human Flu
• Genomic Medicine: Hope for Rare Disease

Archives

Archives Select Month April 2025 (3) March 2025 (1) February 2025 (2) January 2025 (2) December 2024 (3) November 2024 (1) October 2024 (2) September 2024 (2) August 2024 (2) July 2024 (2) June 2024 (3) October 2022 (1) September 2022 (2) August 2022 (2) July 2022 (2) June 2022 (2) May 2022 (2) April 2022 (1) March 2022 (3) April 2021 (1) March 2021 (4) February 2021 (4) January 2021 (5) December 2020 (3) November 2020 (3) October 2020 (4) September 2020 (4) August 2020 (4) July 2020 (4) June 2020 (4) May 2020 (6) April 2020 (4) March 2020 (3) February 2020 (5) January 2020 (3) December 2019 (4) November 2019 (4) October 2019 (3) September 2019 (2) August 2019 (3) July 2019 (5) June 2019 (6) May 2019 (4) April 2019 (3) March 2019 (5) February 2019 (4) January 2019 (3) December 2018 (4) November 2018 (3) October 2018 (3) September 2018 (4) August 2018 (4) July 2018 (4) June 2018 (4) May 2018 (3) April 2018 (5) March 2018 (5) February 2018 (4) January 2018 (5) December 2017 (5) November 2017 (4) October 2017 (5) September 2017 (5) August 2017 (5) July 2017 (5) June 2017 (6) May 2017 (6) April 2017 (5) March 2017 (6) February 2017 (5) January 2017 (5) December 2016 (5) November 2016 (5) October 2016 (5) September 2016 (5) August 2016 (4) July 2016 (5) June 2016 (5) May 2016 (8) April 2016 (7) March 2016 (8) February 2016 (7) January 2016 (7) December 2015 (5) November 2015 (8) October 2015 (7) September 2015 (6) August 2015 (5) July 2015 (4) June 2015 (5) May 2015 (4) April 2015 (5) March 2015 (5) February 2015 (3) January 2015 (5) December 2014 (5) November 2014 (4) October 2014 (3) September 2014 (5) August 2014 (4) July 2014 (5) June 2014 (4) May 2014 (6) April 2014 (8) March 2014 (6) February 2014 (5) January 2014 (6) December 2013 (8) November 2013 (5) October 2013 (4) September 2013 (4) August 2013 (5) July 2013 (4) June 2013 (5) May 2013 (7) April 2013 (3) February 2013 (1) November 2012 (2) ABOUT USHOW IT WORKSBLOG NEWS PARTNERS CONTACT US PRIVACY POLICY TERMS OF USE FROM OUR BLOG LATEST NEWS CONNECT WITH US © 2026 Medivizor popup

Thanks for your interest in Medivizor

Now, please tell us the medical condition you’re interested in.

Medical Condition email error

Invalid email

Please provide a valid email address.